Just a couple of short weeks before its next Unpacked event, Samsung has revealed that it shipped "almost 10 million foldable smartphones" worldwide. In a post on the Samsung Newsroom, the company's chief of Mobile Experience (MX) Business, Dr. TM Roh, said that's a 300 percent increase from 2020 and that he expects what he calls "fast-paced growth" to continue. Most of its foldable customers, 70 percent of them apparently, went for the clamshell-like Flip. That's not surprising in the least: Samsung previously admitted that the Flip 3 motivated more people to switch brands than its flagships did.

The 10 million units Roh claims Samsung shipped last year is considerably larger than the shipment numbers IDC previously published, though. In a report by the International Data Corporation in February, it said it "witnessed worldwide shipments of foldable phones, inclusive of both flip and fold form factors, reach a total of 7.1 million units in 2021." Whichever figure is true, Samsung's MX division posted an increase in revenue last year, mostly due to the strong sales of its foldables and its latest Galaxy S devices.

In addition to giving an update on how Samsung's devices are doing, Roh has also confirmed that the company is introducing its next Flip and Fold models at its next Unpacked event. He also said Samsung made advancements to enhance users' experiences with the upcoming devices:

"I am excited to see people to discover new ways to do more of the things they love with the new foldable.... At our upcoming Unpacked on August 10th, you’ll see that the impact of our innovation is not only about what technology can do. It’s about what you can do. We’ve once again taken our inspiration from the most important source — Galaxy users — to push the limits of what’s possible. I can’t wait to show you the potential of our new Samsung Galaxy foldables as the ultimate tool for both productivity and self-expression."

Samsung's upcoming Unpacked event will take place on August 10th at 9AM ET. Join us at our YouTube channel to tune into our coverage, which begins at around 8:40AM.

Ford Motor Co on Thursday announced a series of deals to accelerate its shift to electric vehicles, including sourcing battery capacity and raw materials. The deals are part of Ford's push to have its annual EV production rate globally reach 600,000 vehicles by late 2023 and more than 2 million by the end of 2026. Ford said it expects a compound annual growth rate for EVs to top 90% through 2026, more than doubling the forecast industry growth rate.

The interminable saga of Cristiano Ronaldo drags on, as he chases money he doesn’t need, in search of a club that doesn’t want him, says Neil Humphreys.

Experts say regulation is essential to protect people's lives as well as India's fragile Himalayan region.

(Bloomberg) -- European stocks steadied and the euro rose Thursday as investors braced for the European Central Bank’s first interest rate hike in 11 years. Russia resumed sending gas to Europe through a key pipeline, dispelling investors’ worst fears. Most Read from BloombergAmericans Who Can’t Afford Homes Are Moving to Europe InsteadThese Are the World’s Most (and Least) Powerful Passports in 2022Kissinger Warns Biden Against Endless Confrontation With ChinaFord Plans Up to 8,000 Job Cuts to

That comes after a costly year in which the company had to get its plant back up and running while providing WIC rebates for competing formulas and paying higher-than-normal airfreight costs.

It is expected to grow at a CAGR of 4. 2% during 2022–2028. The growth of the breakfast cereals market is driven by the rise in product offerings by breakfast cereals manufacturers. People are highly conscious about their health, particularly the young generation, creating a high demand for packed and ready-to-eat food products with high protein content, which are gluten-free and contain zero additives.New York, July 21, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the repo

SHERIDAN, WY, July 21, 2022 (GLOBE NEWSWIRE) -- Despite the attractiveness of the promise to make money in Play-to-Earn games, there are two major reasons why traditional gamers refuse to adopt web3 gaming: first, the quality of gameplay of the web3 pioneers apparently falls short of the AAA web2 blockbusters; and second, purchasing cryptocurrency and NFTs, in general, is such a complicated process to those who are not accustomed to it. From the creators of Bladebound, comes the first high-quali

An initial seizure of meth led investigators to get a search warrant for a home in Lexington, where they allegedly found 43 pounds of crystal meth and several other drugs.

An unprecedented rush for Women's Euros tickets began on Thursday morning as newly-released tickets for England's semi-final at Bramall Lane were snapped up off the back of the Lionesses' dramatic extra-time win over Spain.

Electrovaya Inc. ("Electrovaya" or the "Company") (TSX:EFL)(OTCQB:EFLVF), a lithium ion battery technology and manufacturing company, today announced that its credit facility has been increased from C$14 million to C$16 million to support its sales growth.

SAN FRANCISCO, July 21, 2022 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology,” Nasdaq: OLMA) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to OP-1250, the Company's novel, oral complete estrogen receptor (ER) antagonist (CERAN) and selective ER degrader (SERD), for the treatment of ER-positive (ER+), human epidermal growth factor receptor 2-negative (HER2-) metastatic breast cancer that has progressed following one

Research will leverage Artizan’s proprietary IgA-SEQ™ discovery platform to identify gut microbiota that may affect the safety and efficacy of immune checkpoint inhibitor therapiesNEW HAVEN, Conn., July 21, 2022 (GLOBE NEWSWIRE) -- Artizan Biosciences, Inc. (“Artizan”), a biotechnology company creating gut exclusive microbial metalloprotease inhibitors (GEMMi), a new class of transformative precision therapeutics that disrupt chronic inflammatory disease triggers, today announced that it has ent

Today, the RD Fund (Retinal Degeneration Fund) – the venture arm of the Foundation Fighting Blindness (the Foundation) aimed at rapidly driving research toward preventions, treatments, and cures for the entire spectrum of retinal degenerative diseases – announced the appointment of Adrienne Graves, PhD, as the chair of its board of directors, and Jean Bennett, MD, PhD, Catherine Bowes Rickman, PhD, and José-Alain Sahel, MD, as directors.

BOGOTA, Colombia, July 21, 2022--GeoPark Limited ("GeoPark" or the "Company") (NYSE: GPRK), a leading independent Latin American oil and gas explorer, operator and consolidator today announces its operational update for the three-month period ended June 30, 2022 ("2Q2022").

- First Dosings completed in Australia- Provides Update on Pending Spin-Out and Renaming to Reunion Neurosciences- Announces 5:1 Share Consolidation Ratio TORONTO, July 21, 2022 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX: FTRP, FTRP.WT, Nasdaq: FTRP) ("Field Trip" or the “Company”), a global leader in the development and delivery of psychedelic therapies, announced today the first successful dosings in the Phase 1 Clinical Study entitled “A Double-Blind, Randomized, Placebo-Controlled Study

SAN JUAN, Puerto Rico, July 21, 2022--OFG Bancorp (NYSE: OFG), the financial holding company for Oriental Bank, reported results for the second quarter ended June 30, 2022. EPS diluted was $0.84 compared to $0.76 in 1Q22 and $0.78 in 2Q21. Total core revenues were $146.3 million compared to $136.4 million in 1Q22 and $133.3 million in 2Q21.

Leading Tier 1 aerospace supplier will collaborate with Lilium to develop, manufacture, and support the Lilium Jet’s cabin interior Lilium Engages Diehl Aviation for Lilium Jet’s Cabin Interior Lilium Engages Diehl Aviation for Lilium Jet’s Cabin Interior MUNICH, Germany, July 21, 2022 (GLOBE NEWSWIRE) -- Lilium N.V. (NASDAQ: LILM) (“Lilium”), developer of the first all-electric vertical take-off and landing (“eVTOL”) jet, has selected Diehl Aviation, a leading supplier of cabin interiors and sy

Harvest Portfolios Group Inc. ("Harvest") declares the monthly cash distribution payable for Big Pharma Split Corp. of $0.1031 for each class A share (TSX: PRM) for the month ending July 29, 2022. The distribution is payable August 9, 2022 to class A shareholders of record at the close of business July 29, 2022.

Sonnet BioTherapeutics Holdings, Inc., (NASDAQ:SONN) a clinical-stage company developing targeted immunotherapeutic drugs, announced today that a second Phase 1 clinical trial of SON-1010(IL12-FHAB) has been authorized to begin, based on the successful initiation of the first two cohorts in the first-in-human (FIH) dose-escalation trial (SB101) in patients with advanced solid tumors (NCT05352750).

Harvest Portfolios Group Inc. ("Harvest") announces the following distributions for Harvest ETFs for the month ending July 29, 2022. The distribution will be paid on or about August 9, 2022 to unitholders of record on July 29, 2022 with an ex-dividend date of July 28, 2022.